19.58
0.01 (0.05%)
| Previous Close | 19.57 |
| Open | 18.88 |
| Volume | 746,722 |
| Avg. Volume (3M) | 663,011 |
| Market Cap | 1,511,945,984 |
| Price / Earnings (Forward) | 5.55 |
| Price / Sales | 0.620 |
| Price / Book | 0.670 |
| 52 Weeks Range | |
| Earnings Date | 5 May 2025 - 9 May 2025 |
| Profit Margin | -1.78% |
| Operating Margin (TTM) | 8.23% |
| Diluted EPS (TTM) | -0.380 |
| Quarterly Revenue Growth (YOY) | 3.70% |
| Quarterly Earnings Growth (YOY) | -2.00% |
| Total Debt/Equity (MRQ) | 132.59% |
| Current Ratio (MRQ) | 1.21 |
| Operating Cash Flow (TTM) | 102.37 M |
| Levered Free Cash Flow (TTM) | 35.55 M |
| Return on Assets (TTM) | 2.66% |
| Return on Equity (TTM) | -1.86% |
Market Trend
| Short Term | Medium Term | ||
| Industry | Medical Devices (US) | Bearish | Mixed |
| Medical Devices (Global) | Bearish | Mixed | |
| Stock | Integra LifeSciences Holdings C | Bearish | Bearish |
AIStockmoo Score
| Analyst Consensus | -3.5 |
| Insider Activity | NA |
| Price Volatility | -2.0 |
| Technical Moving Averages | 2.5 |
| Technical Oscillators | -2.0 |
| Average | -1.25 |
|
Integra Lifesciences Holdings Corp is a New Jersey-based medical equipment company focused on developing products for regenerative therapy, extremity orthopedics, and neurosurgical applications. The firm is organized into two primary segments: Codman specialty surgical and tissue technologies. Codman Specialty Surgical generates maximum revenue from its segmental operations. Integra serves Europe, Asia Pacific, and the rest of the world whilst it derives key revenue from domestic sales. |
|
| Sector | Healthcare |
| Industry | Medical Devices |
| Investment Style | Small Value |
| % Held by Insiders | 14.23% |
| % Held by Institutions | 96.62% |
| 52 Weeks Range | ||
| Price Target Range | ||
| High | 25.00 (JMP Securities, 27.68%) | Buy |
| Median | 16.00 (-18.28%) | |
| Low | 12.00 (JP Morgan, -38.71%) | Sell |
| Average | 17.25 (-11.90%) | |
| Total | 1 Buy, 2 Hold, 1 Sell | |
| Avg. Price @ Call | 13.69 | |
| Firm | Date | Target Price | Call | Price @ Call |
|---|---|---|---|---|
| JMP Securities | 09 May 2025 | 25.00 (27.68%) | Buy | 12.25 |
| JP Morgan | 06 May 2025 | 12.00 (-38.71%) | Sell | 12.75 |
| Wells Fargo | 06 May 2025 | 13.00 (-33.61%) | Hold | 12.75 |
| Truist Securities | 11 Apr 2025 | 19.00 (-2.96%) | Hold | 16.99 |
No data within this time range.
| Date | Type | Details |
|---|---|---|
| 05 May 2025 | Announcement | Integra LifeSciences Reports First Quarter 2025 Financial Results |
| 18 Apr 2025 | Announcement | Integra LifeSciences to Host First Quarter 2025 Financial Results Conference Call on May 5, 2025 |
The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.
Portfolio
| Realized Profit | - |
| Unrealized Profit | - |
| Dividend Received 2025 | - |
| Total Profit | - |
| Avg. Return | - |
| Quantity (Buy) | - |
| Avg. Price (Buy) | - |
| Quantity (Sold) | - |
| Avg. Price (Sold) | - |